David has now completed 3 cycles of Vidaza. He had a bone marrow biopsy several weeks ago. At first we thought the results were good, that his cancer cells had been reduced sufficiently to proceed with transplant. After our local oncologist spoke to the transplant specialist at Mayo, we received word that Mayo wants another cycle of Vidaza, this time with Venetoclax added. Apparently chromosomal analysis of the bone marrow led to this change. Also the Mayo specialist set benchmarks for his blood counts to be met before he can receive the chemotherapy, with levels that he has not been at in months (possibly years). He has in fact been needing transfusions two or three times per week since December. I am completely confused by the plan. He has never had Venetoclax before and we are concerned about side effects.
I will keep trying to get clearer communication from the transplant team.
The good news is, they have identified a primary and a secondary donor for the stem cell transplant. They tell us to plan to proceed in 8 weeks.
In other news, extensive studies of the bone marrow showed zero CLL. but "only 20% cellularity." Not much going on in his battered bone marrow, and apparently what is there ain't good.